TherapeuticsMD, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TXMD | DERM | AQST | CRDL | ORGO | SBFM | |
|---|---|---|---|---|---|---|
| Market cap | 23.38M | 166.81M | 603.71M | 143.39M | 158.27M | 1.30M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | 5.8 | -98.5 | -8.4 | -5.2 | -4.0 | 0.0 |
| Price/book | 0.9 | 5.1 | -10.7 | 8.1 | 1.1 | 0.0 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +96.19% | −9.86% | −30.09% | +17.14% | −67.34% | −97.83% |
| Today | −1.94% | −6.34% | +0.63% | −4.07% | −4.65% | −10.60% |
The closest companies by business and industry (Drug Manufacturers - Specialty & Generic). Prices may be delayed up to 15 min.
Latest news
All TXMD news ›GSK (NYSE:GSK) vs. TherapeuticsMD (NASDAQ:TXMD) Financial Comparison
Posted by Defense World Staff on Oct 8th, 2026 TherapeuticsMD (NASDAQ:TXMD – Get Free Report) and GSK (NYSE:GSK – Get Free Report) are both healthcare companies, but which is the superior stock? We will contrast the two companies based on…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
-
defenseworld.net1
Finance and business coverage in the 4Conservative news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 1 articles, not a forecast.